Literature DB >> 16478179

Total synthesis and structural elucidation of azaspiracid-1. Synthesis-based analysis of originally proposed structures and indication of their non-identity to the natural product.

K C Nicolaou1, David Y-K Chen, Yiwei Li, Noriaki Uesaka, Goran Petrovic, Theocharis V Koftis, Federico Bernal, Michael O Frederick, Mugesh Govindasamy, Taotao Ling, Petri M Pihko, Wenjun Tang, Stepan Vyskocil.   

Abstract

The key building blocks (6, 7, and 8) for the intended construction of the originally proposed structures of azaspiracid-1, a potent marine-derived neurotoxin, were coupled and the products elaborated to the targeted compounds (1a,b) and their C-20 epimers (2 and 3). The assembly of the three intermediates was accomplished by a dithiane-based coupling reaction that united the C(1)-C(20) (7) and C(21)-C(27) (8) fragments, followed by a Stille-type coupling which allowed the incorporation of the C(28)-C(40) fragment (6) into the growing substrate. Neither of the final products (1a,b) matched the natural substance by TLC or (1)H NMR spectroscopic analysis, suggesting one or more errors in the originally proposed structure for this notorious biotoxin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478179     DOI: 10.1021/ja054748z

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  13 in total

Review 1.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

2.  Synthesis of the southern FGHI ring system of azaspiracid-1 and investigation into the controlling elements of C28- and C36-ketalization.

Authors:  Xiao-Ti Zhou; Liang Lu; Daniel P Furkert; Charles E Wells; Rich G Carter
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-20       Impact factor: 15.336

3.  Total synthesis of atrochamins F, H, I, and J through cascade reactions.

Authors:  K C Nicolaou; Troy Lister; Ross M Denton; Christine F Gelin
Journal:  Tetrahedron       Date:  2008-05-19       Impact factor: 2.457

4.  Monoclonal antibodies with orthogonal azaspiracid epitopes.

Authors:  Michael O Frederick; Sandra De Lamo Marin; Kim D Janda; K C Nicolaou; Tobin J Dickerson
Journal:  Chembiochem       Date:  2009-07-06       Impact factor: 3.164

5.  Synthetic and Computational Studies on the ABC Trioxadispiroketal Subunit of the Marine Biotoxin Azaspiracid-1.

Authors:  Jialiang Li; Xiaohua Li; David R Mootoo
Journal:  Nat Prod Commun       Date:  2008-11       Impact factor: 0.986

6.  Synthesis-guided structure revision of the sarcodonin, sarcoviolin, and hydnellin natural product family.

Authors:  David W Lin; Takeshi Masuda; Moritz B Biskup; Jonathan D Nelson; Phil S Baran
Journal:  J Org Chem       Date:  2011-01-20       Impact factor: 4.354

7.  Microsphere-based immunoassay for the detection of azaspiracids.

Authors:  Laura P Rodríguez; Natalia Vilariño; M Carmen Louzao; Tobin J Dickerson; K C Nicolaou; Michael O Frederick; Luis M Botana
Journal:  Anal Biochem       Date:  2013-11-08       Impact factor: 3.365

8.  Azaspiracid substituent at C1 is relevant to in vitro toxicity.

Authors:  Natalia Vilariño; K C Nicolaou; Michael O Frederick; Eva Cagide; Carmen Alfonso; Eva Alonso; Mercedes R Vieytes; Luis M Botana
Journal:  Chem Res Toxicol       Date:  2008-08-16       Impact factor: 3.739

9.  In vitro chronic effects on hERG channel caused by the marine biotoxin azaspiracid-2.

Authors:  Sara F Ferreiro; Natalia Vilariño; M Carmen Louzao; K C Nicolaou; Michael O Frederick; Luis M Botana
Journal:  Toxicon       Date:  2014-10-05       Impact factor: 3.033

10.  Involvement of caspase activation in azaspiracid-induced neurotoxicity in neocortical neurons.

Authors:  Zhengyu Cao; Keith T LePage; Michael O Frederick; Kyriacos C Nicolaou; Thomas F Murray
Journal:  Toxicol Sci       Date:  2010-01-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.